SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Clovis Oncology, Inc. and a Lea...
November 24 2015 - 3:54PM
The Law Offices of Vincent Wong announce that a class action
lawsuit has been commenced in the USDC for the District of Colorado
on behalf of investors who purchased Clovis Oncology, Inc.
(NASDAQ:CLVS) securities between May 20, 2014 and November 13,
2015.
Click here to learn about the case:
http://docs.wongesq.com/CLVS-Info-Request-Form-1004.
There is no cost or obligation to you.
The complaint alleges that throughout the Class
Period, defendants made false and misleading statements and/or
failed to disclose that: (1) the New Drug Application (“NDA”) that
Clovis submitted to the FDA for rociletinib contained immature data
sets based on both unconfirmed response rates and confirmed
response rates; (2) Clovis’ Breakthrough Therapy designation
submission contained immature data sets based primarily on
unconfirmed responses; (3) Clovis presented interim data publicly
and at medical meetings that included a data set based primarily on
unconfirmed responses; (4) as the efficacy data matured, the number
of patients with an unconfirmed response who converted to a
confirmed response was lower than expected; and (5) as a result of
the foregoing, Clovis’ NDA was likely to be delayed and/or rejected
by the FDA.
If you suffered a loss in Clovis
Oncology you have until January 18, 2016 to request that
the Court appoint you as lead plaintiff. Your ability to share in
any recovery doesn’t require that you serve as a lead plaintiff. To
obtain additional information, contact Vincent Wong, Esq. either
via email vw@wongesq.com, by telephone at 212.425.1140, or visit
http://docs.wongesq.com/CLVS-Info-Request-Form-1004.
Vincent Wong, Esq. is an experienced attorney
that has represented investors in securities litigations involving
financial fraud and violations of shareholder rights.
Attorney advertising. Prior results do not guarantee similar
outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Apr 2024 to May 2024
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Clovis Oncology Inc (NASDAQ): 0 recent articles
More News Articles